ANI Pharma (ANIP) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
ANI Pharmaceuticals Reports First Quarter 2015 Financial Results
May 5, 2015 8:00 AM EDTBAUDETTE, Minn., May 5, 2015 /PRNewswire/ --Â ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three months ended March 31, 2015 and reaffirmed its revenue, non-GAAP EBITDA, and non-GAAP earnings per share guidance for 2015.
First Quarter 2015 Highlights Include:
First quarter net revenues of $18.8Â million, an increase of 72% as compared to $10.9 million for the same period in 2014. First quarter adjusted non-GAAP EBITDA of $11.5Â million, an increase of 170% as compared to $4.2 million for the same period in 2014. First quarter operating income of $9.6 million, an increase... More